{"gene":"CBX8","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":2007,"finding":"CBX8, as part of a PRC1 complex, directly binds to the INK4A-ARF locus and represses it, leading to bypass of senescence and cellular immortalization when CBX8 is ectopically expressed in diploid human and mouse fibroblasts.","method":"ChIP (location analysis), ectopic expression, gene expression profiling, loss-of-function in fibroblasts","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — reciprocal ChIP and functional KO/OE with defined cellular phenotype (senescence bypass), replicated across human and mouse cells","pmids":["17332741"],"is_preprint":false},{"year":2011,"finding":"CBX8 interacts with MLL-AF9 and TIP60, and is required for MLL-AF9-induced transcriptional activation of HOX genes and leukemic transformation; point mutations disrupting the CBX8–MLL-AF9 interaction abrogate HOX gene upregulation and abolish leukemogenesis.","method":"Co-immunoprecipitation, point mutation analysis, Cbx8 knockout mice, retroviral transformation assays, gene expression analysis","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, point-mutation disruption, and clean KO with defined leukemia phenotype","pmids":["22094252"],"is_preprint":false},{"year":2016,"finding":"CBX8 is induced in germinal center B cells, binds H3K27me3 at bivalent promoters via its chromodomain, and is required for stable association of a non-canonical PRC1-BCOR-CBX8 complex assembled by EZH2 and BCL6, mediating histone modifications and GC formation.","method":"ChIP-seq, Co-IP, genetic knockdown, functional GC formation assays","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 — ChIP-seq, Co-IP, and KD with defined cellular phenotype (GC formation), multiple orthogonal methods","pmids":["27505670"],"is_preprint":false},{"year":2014,"finding":"A Cbx8-containing PRC1 complex facilitates transcriptional activation of differentiation genes during ES cell differentiation; Cbx8 transiently recruits to bivalent promoters during early gene activation and is required for efficient activation, with exchange of Cbx7 for Cbx8 being necessary for this process.","method":"ChIP-seq of endogenous Cbx8, interaction analysis (co-IP), siRNA depletion, microarray gene expression","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 — genome-wide ChIP-seq, interaction analysis, and depletion with defined transcriptional phenotype in ES cells","pmids":["25500566"],"is_preprint":false},{"year":2019,"finding":"The CBX8 chromodomain drives chromatin association through dual binding to both H3K27me3 histone marks and DNA; structural characterization revealed how histone and DNA binding integrate, and both activities were required for CBX8 chromatin association in vivo.","method":"Biochemical binding assays (in vitro), structural characterization, ChIP in cells, mutagenesis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution and structural characterization combined with in vivo ChIP validation and mutagenesis","pmids":["30597065"],"is_preprint":false},{"year":2019,"finding":"A selective, cell-permeable CBX8 chromodomain inhibitor (SW2_110A) developed via DNA-encoded library selection binds the CBX8 ChD with Kd ~800 nM, specifically inhibits CBX8 chromatin association in cells, and reduces MLL-AF9 target gene (HOXA9) expression and proliferation of THP1 leukemia cells, validating the chromodomain as necessary for CBX8's role in MLL-AF9 transcriptional activation.","method":"DNA-encoded library selection, fluorescence polarization, cell-based chromatin association assay, gene expression analysis, proliferation assay","journal":"ACS chemical biology","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro binding assay with selectivity profiling, cell-permeable probe with functional cellular readout","pmids":["31755685"],"is_preprint":false},{"year":2017,"finding":"CBX8 activates AKT/β-catenin signaling in hepatocellular carcinoma in a non-canonical manner: CBX8 directly binds the EGR1 promoter to enhance transcription and also interacts with EGR1 protein in the nucleus to prevent its degradation; additionally, CBX8 upregulates miR-365a-3p which promotes nuclear β-catenin localization by targeting ZNRF1.","method":"ChIP, co-immunoprecipitation, luciferase reporter assay, siRNA knockdown, ectopic expression, in vivo xenograft","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — ChIP, Co-IP, reporter assay, and in vivo validation with multiple orthogonal methods","pmids":["29066512"],"is_preprint":false},{"year":2016,"finding":"CBX8 accumulates rapidly at sites of DNA damage within 30 seconds in a PARP1-dependent (but ATM-independent) manner; CBX8 biochemically interacts with TRIM33, and its recruitment to DNA damage sites requires TRIM33; CBX8 knockdown reduces efficiency of both homologous and non-homologous recombination and increases sensitivity to ionizing radiation.","method":"Live-cell imaging, co-immunoprecipitation, siRNA knockdown, DNA repair assays (HR/NHEJ reporters), clonogenic survival","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — live imaging with defined kinetics, Co-IP, and loss-of-function with functional DNA repair readouts","pmids":["27555324"],"is_preprint":false},{"year":2014,"finding":"CBX8 knockdown in colorectal cancer cells inhibits proliferation (partly by increasing p53 and downstream effectors) but paradoxically enhances migration, invasion and metastasis through direct upregulation of integrin β4 (ITGB4), which in turn decreases RhoA activity.","method":"siRNA knockdown, in vitro migration/invasion assays, in vivo metastasis assay, gene expression analysis, ChIP","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 — KD with defined cellular phenotypes (proliferation, migration) and mechanistic target identification, single lab","pmids":["25360999"],"is_preprint":false},{"year":2017,"finding":"CBX8 suppresses tumor metastasis in esophageal squamous cell carcinoma by directly binding the Snail promoter and repressing its transcription, thereby inhibiting EMT; CBX8 expression inversely correlates with Snail in ESCC tissues.","method":"ChIP, luciferase reporter assay, siRNA/overexpression, migration/invasion assays, in vivo metastasis model","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and reporter assay with functional readout, single lab","pmids":["28912889"],"is_preprint":false},{"year":2019,"finding":"CBX8 promotes LGR5 transcription in a non-canonical manner by recruiting KMT2b to the LGR5 promoter, maintaining H3K4me3 status; additionally, m6A methylation upregulates CBX8 by maintaining CBX8 mRNA stability.","method":"ChIP-seq, RNA-seq, ChIP, co-immunoprecipitation, dual luciferase reporter assay, IP","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-seq, Co-IP, reporter assays with multiple orthogonal methods, single lab","pmids":["31849331"],"is_preprint":false},{"year":2021,"finding":"KPNA2 promotes nuclear import of CBX8; once nuclear, CBX8 downregulates PRDM1 by recruiting BCOR to the PRDM1 promoter region, leading to suppression of the PRDM1/c-FOS pathway and promotion of bladder cancer progression.","method":"Co-immunoprecipitation, ChIP, siRNA knockdown, overexpression, in vivo mouse model","journal":"Journal of translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP, ChIP, and functional KD/OE with defined pathway, single lab","pmids":["33731128"],"is_preprint":false},{"year":2019,"finding":"CBX8 promotes tumorigenesis in esophageal squamous cell carcinoma by downregulating APAF1 expression (identified via transcriptome sequencing), thereby suppressing the mitochondrial apoptotic pathway and conferring radioresistance.","method":"Transcriptome sequencing, ChIP (implied), siRNA knockdown, apoptosis assays, irradiation survival assay","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 — transcriptome sequencing combined with functional rescue (APAF1 depletion abrogates CBX8-KD apoptosis), single lab","pmids":["31255735"],"is_preprint":false},{"year":2015,"finding":"CBX8 suppresses Sirtinol-induced premature senescence in K562 CML cells by enhancing phosphorylation of AKT1, p27KIP1, and RB, thereby promoting E2F1 transcriptional activity; CBX8 knockdown reverses this effect, placing CBX8 in the AKT-RB-E2F1 pathway.","method":"CBX8 overexpression and siRNA knockdown, Western blot for pathway components, senescence assays","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 — OE/KD with pathway component analysis, single lab, no direct binding assay","pmids":["26718407"],"is_preprint":false},{"year":2020,"finding":"CBX8 promotes invasion and migration in glioblastoma, breast cancer, and lung cancer by binding the WNK2 promoter to suppress WNK2 expression; reduced WNK2 leads to elevated MMP2 and RAC1 activity, which drive invasion and migration respectively.","method":"ChIP, siRNA knockdown, overexpression, invasion/migration assays, in vivo xenograft","journal":"Molecular therapy oncolytics","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP with functional validation in multiple cancer types, single lab","pmids":["33251331"],"is_preprint":false},{"year":2015,"finding":"IGF1 increases CBX8 expression in HCT116 colon cancer cells; CBX8 overexpression promotes proliferation (upregulates CyclinD1) and knockdown induces apoptosis, placing CBX8 downstream of IGF1 signaling in colon cancer.","method":"Gene silencing (siRNA), overexpression, Western blot, RT-PCR, cell proliferation assay","journal":"Cell biochemistry and biophysics","confidence":"Low","confidence_rationale":"Tier 3 — single lab, single method set (KD/OE + Western blot), no direct binding or mechanistic detail","pmids":["25398592"],"is_preprint":false},{"year":2019,"finding":"CBX8 interacts with YBX1, and YBX1-mediated regulation of CyclinD1 is required for CBX8-driven cell cycle progression and proliferation in hepatocellular carcinoma cells; YBX1 knockdown compromises proliferation of CBX8-overexpressing cells.","method":"Co-immunoprecipitation, siRNA knockdown, overexpression, Western blot, GSEA","journal":"Aging","confidence":"Low","confidence_rationale":"Tier 3 — Co-IP and KD with functional readout, single lab, no structural detail","pmids":["31495785"],"is_preprint":false},{"year":2018,"finding":"DNA-encoded positional scanning library selections against the CBX8 chromodomain identified peptidomimetic ligands with increased potency and selectivity for CBX8 ChD over CBX7 ChD, characterizing the structural requirements for selective ChD binding.","method":"DNA-encoded library affinity selection, fluorescence polarization, sequencing","journal":"SLAS discovery","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro biochemical assay with quantitative SAR, validated off-DNA with FP, single lab","pmids":["29309209"],"is_preprint":false}],"current_model":"CBX8 is a chromodomain-containing Polycomb group protein that associates with PRC1 complexes and binds H3K27me3 and DNA via its chromodomain to regulate chromatin state; it represses key loci (including INK4A-ARF) to bypass senescence, functions in a non-canonical activating capacity during ES cell differentiation, is required for MLL-AF9–driven leukemogenesis through interaction with MLL-AF9 and TIP60, participates in PARP1-dependent DNA damage response via interaction with TRIM33, and modulates cancer cell proliferation and metastasis through context-dependent transcriptional regulation of targets including Snail, WNK2, APAF1, and LGR5."},"narrative":{"teleology":[{"year":2007,"claim":"Establishing CBX8 as a PRC1 component that directly represses the INK4A-ARF tumor suppressor locus resolved how Polycomb chromobox proteins control replicative senescence and cellular immortalization.","evidence":"ChIP at INK4A-ARF, ectopic expression in human/mouse fibroblasts causing senescence bypass","pmids":["17332741"],"confidence":"High","gaps":["How CBX8 is selectively recruited to INK4A-ARF versus other PRC1 targets was not addressed","Whether CBX8's chromodomain histone-binding activity is required for INK4A-ARF repression was untested"]},{"year":2011,"claim":"Demonstrating that CBX8 physically interacts with MLL-AF9 and TIP60 and is essential for HOX gene activation and leukemic transformation revealed an unexpected non-canonical activating role for a Polycomb protein in oncogenesis.","evidence":"Co-IP, point-mutation disruption of CBX8–MLL-AF9 interaction, Cbx8 knockout mice, retroviral transformation assays","pmids":["22094252"],"confidence":"High","gaps":["Whether TIP60 acetyltransferase activity is the effector downstream of CBX8 recruitment was not tested","Structural basis of the CBX8–MLL-AF9 interaction was not determined"]},{"year":2014,"claim":"Showing that Cbx8 transiently replaces Cbx7 at bivalent promoters during ES cell differentiation to enable gene activation established a Polycomb subunit-switching mechanism controlling developmental transcription.","evidence":"Endogenous Cbx8 ChIP-seq, Co-IP, siRNA depletion, microarray in differentiating ES cells","pmids":["25500566"],"confidence":"High","gaps":["The signal triggering the Cbx7-to-Cbx8 switch was not identified","Whether the activating PRC1 complex containing Cbx8 has a distinct subunit composition from canonical PRC1 was not fully resolved"]},{"year":2016,"claim":"Two studies expanded CBX8's mechanistic repertoire: identification of a non-canonical PRC1-BCOR-CBX8 complex at bivalent promoters in germinal center B cells, and discovery of rapid PARP1/TRIM33-dependent CBX8 recruitment to DNA damage sites required for both HR and NHEJ.","evidence":"ChIP-seq and Co-IP with GC formation assays (GC study); live-cell imaging, Co-IP with TRIM33, HR/NHEJ reporter assays (DNA damage study)","pmids":["27505670","27555324"],"confidence":"High","gaps":["How TRIM33 physically recruits CBX8 to damage sites and whether the chromodomain is required for this function were not determined","Whether PRC1-BCOR-CBX8 complex has distinct enzymatic activity (e.g., ubiquitin ligase) compared to canonical PRC1 was not tested"]},{"year":2017,"claim":"Context-dependent transcriptional regulation by CBX8 was elaborated in cancer: CBX8 activates EGR1/AKT/β-catenin signaling in hepatocellular carcinoma while repressing Snail to suppress EMT in esophageal squamous cell carcinoma, illustrating dual activator/repressor functions at different loci.","evidence":"ChIP, Co-IP, luciferase reporters, siRNA/overexpression, in vivo metastasis models in HCC and ESCC","pmids":["29066512","28912889"],"confidence":"High","gaps":["What determines whether CBX8 acts as an activator versus repressor at a given promoter is unknown","Whether these cancer-context functions depend on PRC1 complex membership was not tested"]},{"year":2018,"claim":"Structure-activity analysis of the CBX8 chromodomain using DNA-encoded library selections identified selective peptidomimetic ligands, defining the structural requirements distinguishing CBX8 from CBX7 chromodomain binding.","evidence":"DNA-encoded library affinity selection with fluorescence polarization validation","pmids":["29309209"],"confidence":"Medium","gaps":["No cell-based validation of these ligands was reported in this study","Co-crystal structure of ligand–CBX8 ChD was not obtained"]},{"year":2019,"claim":"Structural and biochemical characterization demonstrated that the CBX8 chromodomain binds both H3K27me3 and DNA simultaneously, and a cell-permeable chromodomain inhibitor validated this dual-binding mode as essential for CBX8 chromatin association and MLL-AF9 target gene expression.","evidence":"In vitro binding assays, structural characterization, mutagenesis, ChIP; DNA-encoded library-derived inhibitor SW2_110A with cellular chromatin association and proliferation assays in THP1 cells","pmids":["30597065","31755685"],"confidence":"High","gaps":["Full atomic-resolution structure of CBX8 ChD bound simultaneously to nucleosomal DNA and H3K27me3 is lacking","Whether inhibitor efficacy extends to in vivo leukemia models was not shown"]},{"year":2019,"claim":"Non-canonical transcriptional activation by CBX8 was further demonstrated at the LGR5 locus, where CBX8 recruits KMT2b to maintain H3K4me3, and CBX8 mRNA itself is stabilized by m6A modification, linking epitranscriptomic regulation to Polycomb function.","evidence":"ChIP-seq, RNA-seq, Co-IP, dual luciferase reporter assay","pmids":["31849331"],"confidence":"Medium","gaps":["Direct interaction between CBX8 and KMT2b was not structurally characterized","Which m6A writer/reader mediates CBX8 mRNA stabilization was not fully identified"]},{"year":2021,"claim":"Identification of KPNA2 as a CBX8 nuclear import factor and demonstration that nuclear CBX8 recruits BCOR to repress PRDM1 in bladder cancer connected nuclear trafficking to CBX8's repressive output.","evidence":"Co-IP, ChIP, siRNA/overexpression, in vivo mouse model","pmids":["33751128"],"confidence":"Medium","gaps":["Whether KPNA2-dependent import is regulated or constitutive was not addressed","Whether CBX8 uses the same BCOR recruitment mechanism in GC B cells and bladder cancer was not compared"]},{"year":null,"claim":"The central unresolved question is what determines whether CBX8 acts as a transcriptional repressor (via PRC1/BCOR) or activator (via MLL-AF9/TIP60/KMT2b) at a given locus, and how its dual H3K27me3-DNA binding mode integrates with these distinct complexes genome-wide.","evidence":"","pmids":[],"confidence":"High","gaps":["No systematic genome-wide comparison of CBX8 activating versus repressive targets with matched complex composition","In vivo efficacy of CBX8 chromodomain inhibitors has not been demonstrated","Whether the DNA damage response role of CBX8 is separable from its PRC1-associated functions is unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[4]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[0,2,3,4]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,3,6,9,10]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,6,7,11]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[2,3,4,7]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[0,2,3,4,10]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,6,9,10]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[7]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[1,5,6]}],"complexes":["PRC1","PRC1-BCOR-CBX8"],"partners":["RING1B","MLL-AF9","TIP60","TRIM33","BCOR","EGR1","YBX1","KMT2B"],"other_free_text":[]},"mechanistic_narrative":"CBX8 is a chromodomain-containing Polycomb group protein that functions as a context-dependent transcriptional regulator, mediating both gene repression within PRC1 complexes and non-canonical transcriptional activation at distinct genomic loci. Its chromodomain drives chromatin association through dual recognition of H3K27me3 and DNA, and CBX8 occupies bivalent promoters where it represses the INK4A-ARF locus to bypass senescence, silences differentiation regulators in germinal center B cells via a non-canonical PRC1-BCOR complex assembled by EZH2/BCL6, and facilitates activation of differentiation genes during ES cell differentiation through Cbx7-to-Cbx8 exchange [PMID:17332741, PMID:27505670, PMID:25500566, PMID:30597065]. CBX8 is required for MLL-AF9-driven leukemogenesis through direct interaction with MLL-AF9 and TIP60, enabling transcriptional activation of HOX genes, and its chromodomain is pharmacologically targetable to block this oncogenic program [PMID:22094252, PMID:31755685]. CBX8 also participates in DNA damage repair by rapid PARP1- and TRIM33-dependent recruitment to damage sites, where it promotes both homologous recombination and non-homologous end joining [PMID:27555324]."},"prefetch_data":{"uniprot":{"accession":"Q9HC52","full_name":"Chromobox protein homolog 8","aliases":["Polycomb 3 homolog","Pc3","hPc3","Rectachrome 1"],"length_aa":389,"mass_kda":43.4,"function":"Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9HC52/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CBX8","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CSNK2B","stoichiometry":0.2},{"gene":"H1F0","stoichiometry":0.2},{"gene":"HIST2H2BE","stoichiometry":0.2},{"gene":"HMGN5","stoichiometry":0.2},{"gene":"NUMA1","stoichiometry":0.2},{"gene":"PARP1","stoichiometry":0.2},{"gene":"TOP1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/CBX8","total_profiled":1310},"omim":[{"mim_id":"617354","title":"CHROMOBOX 8; CBX8","url":"https://www.omim.org/entry/617354"},{"mim_id":"608457","title":"CHROMOBOX 7; CBX7","url":"https://www.omim.org/entry/608457"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CBX8"},"hgnc":{"alias_symbol":["RC1","HPC3","PC3"],"prev_symbol":[]},"alphafold":{"accession":"Q9HC52","domains":[{"cath_id":"2.40.50.40","chopping":"8-68","consensus_level":"high","plddt":92.0392,"start":8,"end":68}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9HC52","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HC52-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HC52-F1-predicted_aligned_error_v6.png","plddt_mean":61.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CBX8","jax_strain_url":"https://www.jax.org/strain/search?query=CBX8"},"sequence":{"accession":"Q9HC52","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9HC52.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9HC52/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9HC52"}},"corpus_meta":[{"pmid":"21432867","id":"PMC_21432867","title":"PC3 is a cell line characteristic of prostatic small cell carcinoma.","date":"2011","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/21432867","citation_count":375,"is_preprint":false},{"pmid":"18834855","id":"PMC_18834855","title":"Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18834855","citation_count":279,"is_preprint":false},{"pmid":"9778250","id":"PMC_9778250","title":"A SWI/SNF-related chromatin remodeling complex, E-RC1, is required for tissue-specific transcriptional regulation by EKLF in vitro.","date":"1998","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/9778250","citation_count":263,"is_preprint":false},{"pmid":"11377414","id":"PMC_11377414","title":"In search of a function for the TIS21/PC3/BTG1/TOB family.","date":"2001","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/11377414","citation_count":216,"is_preprint":false},{"pmid":"27505670","id":"PMC_27505670","title":"EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis.","date":"2016","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/27505670","citation_count":201,"is_preprint":false},{"pmid":"18339862","id":"PMC_18339862","title":"PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells.","date":"2008","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/18339862","citation_count":184,"is_preprint":false},{"pmid":"17332741","id":"PMC_17332741","title":"Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus.","date":"2007","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17332741","citation_count":160,"is_preprint":false},{"pmid":"22094252","id":"PMC_22094252","title":"CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis.","date":"2011","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/22094252","citation_count":136,"is_preprint":false},{"pmid":"8449925","id":"PMC_8449925","title":"Purification and characterization of the prohormone convertase PC1(PC3).","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8449925","citation_count":116,"is_preprint":false},{"pmid":"31849331","id":"PMC_31849331","title":"m6A modification-mediated CBX8 induction regulates stemness and chemosensitivity of colon cancer via upregulation of LGR5.","date":"2019","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31849331","citation_count":108,"is_preprint":false},{"pmid":"10974444","id":"PMC_10974444","title":"Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells.","date":"2000","source":"International journal of radiation oncology, biology, physics","url":"https://pubmed.ncbi.nlm.nih.gov/10974444","citation_count":100,"is_preprint":false},{"pmid":"7836407","id":"PMC_7836407","title":"Differences in pH optima and calcium requirements for maturation of the prohormone convertases PC2 and PC3 indicates different intracellular locations for these events.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7836407","citation_count":87,"is_preprint":false},{"pmid":"9792133","id":"PMC_9792133","title":"5-Lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell death.","date":"1998","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/9792133","citation_count":83,"is_preprint":false},{"pmid":"8290389","id":"PMC_8290389","title":"Effect of epidermal growth factor on prostate cancer cell line PC3 growth and invasion.","date":"1994","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/8290389","citation_count":80,"is_preprint":false},{"pmid":"17340628","id":"PMC_17340628","title":"Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3.","date":"2007","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17340628","citation_count":78,"is_preprint":false},{"pmid":"19509250","id":"PMC_19509250","title":"Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin.","date":"2009","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/19509250","citation_count":77,"is_preprint":false},{"pmid":"15056715","id":"PMC_15056715","title":"Dual control of neurogenesis by PC3 through cell cycle inhibition and induction of Math1.","date":"2004","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15056715","citation_count":75,"is_preprint":false},{"pmid":"17531530","id":"PMC_17531530","title":"Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17531530","citation_count":75,"is_preprint":false},{"pmid":"29066512","id":"PMC_29066512","title":"CBX8 Exhibits Oncogenic Activity via AKT/β-Catenin Activation in Hepatocellular Carcinoma.","date":"2017","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29066512","citation_count":69,"is_preprint":false},{"pmid":"9186547","id":"PMC_9186547","title":"Effects of alendronate and taxol on PC-3 ML cell bone metastases in SCID mice.","date":"1996","source":"Invasion & metastasis","url":"https://pubmed.ncbi.nlm.nih.gov/9186547","citation_count":64,"is_preprint":false},{"pmid":"12360398","id":"PMC_12360398","title":"BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells.","date":"2002","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/12360398","citation_count":64,"is_preprint":false},{"pmid":"28362855","id":"PMC_28362855","title":"Inhibition of ANO1 by luteolin and its cytotoxicity in human prostate cancer PC-3 cells.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28362855","citation_count":64,"is_preprint":false},{"pmid":"17371797","id":"PMC_17371797","title":"Inhibition of medulloblastoma tumorigenesis by the antiproliferative and pro-differentiative gene PC3.","date":"2007","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/17371797","citation_count":59,"is_preprint":false},{"pmid":"31755685","id":"PMC_31755685","title":"Optimization of Ligands Using Focused DNA-Encoded Libraries To Develop a Selective, Cell-Permeable CBX8 Chromodomain Inhibitor.","date":"2019","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/31755685","citation_count":58,"is_preprint":false},{"pmid":"25500566","id":"PMC_25500566","title":"A Cbx8-containing polycomb complex facilitates the transition to gene activation during ES cell differentiation.","date":"2014","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25500566","citation_count":55,"is_preprint":false},{"pmid":"11749777","id":"PMC_11749777","title":"Effect of scopoletin on PC3 cell proliferation and apoptosis.","date":"2001","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/11749777","citation_count":55,"is_preprint":false},{"pmid":"25360999","id":"PMC_25360999","title":"Paradoxical role of CBX8 in proliferation and metastasis of colorectal cancer.","date":"2014","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25360999","citation_count":51,"is_preprint":false},{"pmid":"19331175","id":"PMC_19331175","title":"The glutamatergic system expression in human PC-3 and LNCaP prostate cancer cells.","date":"2009","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19331175","citation_count":49,"is_preprint":false},{"pmid":"11930152","id":"PMC_11930152","title":"PC3 potentiates NGF-induced differentiation and protects neurons from apoptosis.","date":"2002","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/11930152","citation_count":45,"is_preprint":false},{"pmid":"28912889","id":"PMC_28912889","title":"CBX8 Suppresses Tumor Metastasis via Repressing Snail in Esophageal Squamous Cell Carcinoma.","date":"2017","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/28912889","citation_count":42,"is_preprint":false},{"pmid":"29309209","id":"PMC_29309209","title":"Robustness of In Vitro Selection Assays of DNA-Encoded Peptidomimetic Ligands to CBX7 and CBX8.","date":"2018","source":"SLAS discovery : advancing life sciences R & D","url":"https://pubmed.ncbi.nlm.nih.gov/29309209","citation_count":42,"is_preprint":false},{"pmid":"12950171","id":"PMC_12950171","title":"The prohormone processing enzyme PC3 is a lipid raft-associated transmembrane protein.","date":"2003","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12950171","citation_count":41,"is_preprint":false},{"pmid":"31331331","id":"PMC_31331331","title":"Characterization of CD44 intracellular domain interaction with RUNX2 in PC3 human prostate cancer cells.","date":"2019","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/31331331","citation_count":40,"is_preprint":false},{"pmid":"10340723","id":"PMC_10340723","title":"Melatonin receptors in PC3 human prostate tumor cells.","date":"1999","source":"Journal of pineal research","url":"https://pubmed.ncbi.nlm.nih.gov/10340723","citation_count":39,"is_preprint":false},{"pmid":"31985311","id":"PMC_31985311","title":"Beneficial effects of genistein in suppression of proliferation, inhibition of metastasis, and induction of apoptosis in PC3 prostate cancer cells.","date":"2020","source":"Archives of physiology and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31985311","citation_count":39,"is_preprint":false},{"pmid":"22510595","id":"PMC_22510595","title":"Cell killing and radiosensitizing effects of atorvastatin in PC3 prostate cancer cells.","date":"2012","source":"Journal of radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/22510595","citation_count":38,"is_preprint":false},{"pmid":"25342300","id":"PMC_25342300","title":"Nobiletin suppresses cell viability through AKT pathways in PC-3 and DU-145 prostate cancer cells.","date":"2014","source":"BMC pharmacology & toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/25342300","citation_count":38,"is_preprint":false},{"pmid":"10585559","id":"PMC_10585559","title":"PC3 overexpression affects the pattern of cell division of rat cortical precursors.","date":"2000","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/10585559","citation_count":37,"is_preprint":false},{"pmid":"27248169","id":"PMC_27248169","title":"MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27248169","citation_count":36,"is_preprint":false},{"pmid":"25402753","id":"PMC_25402753","title":"Hsp90 C-terminal inhibitors exhibit antimigratory activity by disrupting the Hsp90α/Aha1 complex in PC3-MM2 cells.","date":"2014","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/25402753","citation_count":36,"is_preprint":false},{"pmid":"26616394","id":"PMC_26616394","title":"NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26616394","citation_count":36,"is_preprint":false},{"pmid":"32712458","id":"PMC_32712458","title":"TNF-α controls Lipocalin-2 expression in PC-3 prostate cancer cells.","date":"2020","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/32712458","citation_count":35,"is_preprint":false},{"pmid":"30597065","id":"PMC_30597065","title":"Engagement of DNA and H3K27me3 by the CBX8 chromodomain drives chromatin association.","date":"2019","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/30597065","citation_count":31,"is_preprint":false},{"pmid":"29721191","id":"PMC_29721191","title":"MicroRNA-652 induces NED in LNCaP and EMT in PC3 prostate cancer cells.","date":"2018","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29721191","citation_count":29,"is_preprint":false},{"pmid":"18679777","id":"PMC_18679777","title":"Simvastatin inducing PC3 prostate cancer cell necrosis mediated by calcineurin and mitochondrial dysfunction.","date":"2008","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/18679777","citation_count":29,"is_preprint":false},{"pmid":"10901441","id":"PMC_10901441","title":"Effects of triptorelin, a gonadotropin-releasing hormone agonist, on the human prostatic cell lines PC3 and LNCaP.","date":"2000","source":"Journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/10901441","citation_count":29,"is_preprint":false},{"pmid":"35910130","id":"PMC_35910130","title":"Quorum Sensing Inhibitory and Quenching Activity of Bacillus cereus RC1 Extracts on Soft Rot-Causing Bacteria Lelliottia amnigena.","date":"2022","source":"ACS omega","url":"https://pubmed.ncbi.nlm.nih.gov/35910130","citation_count":28,"is_preprint":false},{"pmid":"25942420","id":"PMC_25942420","title":"Galectin-3 Overrides PTRF/Cavin-1 Reduction of PC3 Prostate Cancer Cell Migration.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25942420","citation_count":28,"is_preprint":false},{"pmid":"9074629","id":"PMC_9074629","title":"Expression of PC3, carboxypeptidase E and enkephalin in human monocyte-derived macrophages as a tool for genetic studies.","date":"1997","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9074629","citation_count":28,"is_preprint":false},{"pmid":"12686457","id":"PMC_12686457","title":"Parathyroid hormone-related protein upregulates integrin expression via an intracrine pathway in PC-3 prostate cancer cells.","date":"2003","source":"Regulatory peptides","url":"https://pubmed.ncbi.nlm.nih.gov/12686457","citation_count":28,"is_preprint":false},{"pmid":"19203631","id":"PMC_19203631","title":"Studies on the origin of the voltammetric response of the PC-3 cell suspension.","date":"2008","source":"Talanta","url":"https://pubmed.ncbi.nlm.nih.gov/19203631","citation_count":26,"is_preprint":false},{"pmid":"30206982","id":"PMC_30206982","title":"Androgen receptor expression reduces stemness characteristics of prostate cancer cells (PC3) by repression of CD44 and SOX2.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30206982","citation_count":26,"is_preprint":false},{"pmid":"35904625","id":"PMC_35904625","title":"Actinomycin D: a novel Pseudomonas aeruginosa quorum sensing inhibitor from the endophyte Streptomyces cyaneochromogenes RC1.","date":"2022","source":"World journal of microbiology & biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/35904625","citation_count":25,"is_preprint":false},{"pmid":"21556577","id":"PMC_21556577","title":"Expression of activin and activin receptors in pc3 human prostatic-cancer cells.","date":"1995","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/21556577","citation_count":25,"is_preprint":false},{"pmid":"12000145","id":"PMC_12000145","title":"Chemosensitivity of human prostate cancer cells PC3 and LNCaP to genistein isoflavone and beta-lapachone.","date":"2002","source":"Biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/12000145","citation_count":25,"is_preprint":false},{"pmid":"25197352","id":"PMC_25197352","title":"CBX8, a novel DNA repair protein, promotes tumorigenesis in human esophageal carcinoma.","date":"2014","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25197352","citation_count":24,"is_preprint":false},{"pmid":"33731128","id":"PMC_33731128","title":"KPNA2 interaction with CBX8 contributes to the development and progression of bladder cancer by mediating the PRDM1/c-FOS pathway.","date":"2021","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33731128","citation_count":24,"is_preprint":false},{"pmid":"27187384","id":"PMC_27187384","title":"Effect of AQP9 Expression in Androgen-Independent Prostate Cancer Cell PC3.","date":"2016","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27187384","citation_count":24,"is_preprint":false},{"pmid":"32377739","id":"PMC_32377739","title":"p53/PGC‑1α‑mediated mitochondrial dysfunction promotes PC3 prostate cancer cell apoptosis.","date":"2020","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/32377739","citation_count":24,"is_preprint":false},{"pmid":"26625775","id":"PMC_26625775","title":"Antitumoral and Antioxidant Potential of Egyptian Propolis Against the PC3 Prostate Cancer Cell Line.","date":"2015","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/26625775","citation_count":24,"is_preprint":false},{"pmid":"17046135","id":"PMC_17046135","title":"Effects of interactions of EGCG and Cd(2+) on the growth of PC-3 cells and their mechanisms.","date":"2006","source":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association","url":"https://pubmed.ncbi.nlm.nih.gov/17046135","citation_count":23,"is_preprint":false},{"pmid":"25828575","id":"PMC_25828575","title":"Intracellular EP2 prostanoid receptor promotes cancer-related phenotypes in PC3 cells.","date":"2015","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/25828575","citation_count":22,"is_preprint":false},{"pmid":"7864855","id":"PMC_7864855","title":"The role of prohormone convertases PC1 (PC3) and PC2 in the cell-specific processing of proglucagon.","date":"1995","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/7864855","citation_count":22,"is_preprint":false},{"pmid":"33251331","id":"PMC_33251331","title":"Upregulated CBX8 Promotes Cancer Metastasis via the WNK2/MMP2 Pathway.","date":"2020","source":"Molecular therapy oncolytics","url":"https://pubmed.ncbi.nlm.nih.gov/33251331","citation_count":21,"is_preprint":false},{"pmid":"18304460","id":"PMC_18304460","title":"Expression of nucleostemin in prostate cancer and its effect on the proliferation of PC-3 cells.","date":"2008","source":"Chinese medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/18304460","citation_count":21,"is_preprint":false},{"pmid":"18459146","id":"PMC_18459146","title":"Selective amino acid restriction differentially affects the motility and directionality of DU145 and PC3 prostate cancer cells.","date":"2008","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18459146","citation_count":21,"is_preprint":false},{"pmid":"31495785","id":"PMC_31495785","title":"Chromobox homolog 8 (CBX8) Interacts with Y-Box binding protein 1 (YBX1) to promote cellular proliferation in hepatocellular carcinoma cells.","date":"2019","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/31495785","citation_count":20,"is_preprint":false},{"pmid":"8206338","id":"PMC_8206338","title":"Expression of PC2 and PC1/PC3 in human pheochromocytomas.","date":"1994","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/8206338","citation_count":20,"is_preprint":false},{"pmid":"34474113","id":"PMC_34474113","title":"Pro-angiogenic effect of PC-3 exosomes in endothelial cells in vitro.","date":"2021","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/34474113","citation_count":20,"is_preprint":false},{"pmid":"26718407","id":"PMC_26718407","title":"CBX8 antagonizes the effect of Sirtinol on premature senescence through the AKT-RB-E2F1 pathway in K562 leukemia cells.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/26718407","citation_count":20,"is_preprint":false},{"pmid":"27483851","id":"PMC_27483851","title":"Enhanced Cytotoxicity of Biomolecules Loaded Metallic Silver Nanoparticles Against Human Liver (HepG2) and Prostate (PC3) Cancer Cell Lines.","date":"2016","source":"Journal of nanoscience and nanotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/27483851","citation_count":19,"is_preprint":false},{"pmid":"28358602","id":"PMC_28358602","title":"In Vitro Incorporation of Radioiodinated Eugenol on Adenocarcinoma Cell Lines (Caco2, MCF7, and PC3).","date":"2017","source":"Cancer biotherapy & radiopharmaceuticals","url":"https://pubmed.ncbi.nlm.nih.gov/28358602","citation_count":19,"is_preprint":false},{"pmid":"19330832","id":"PMC_19330832","title":"TMF/ARA160 downregulates proangiogenic genes and attenuates the progression of PC3 xenografts.","date":"2009","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19330832","citation_count":19,"is_preprint":false},{"pmid":"31255735","id":"PMC_31255735","title":"CBX8 promotes tumorigenesis and confers radioresistance in esophageal squamous cell carcinoma cells through targeting APAF1.","date":"2019","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/31255735","citation_count":18,"is_preprint":false},{"pmid":"30609788","id":"PMC_30609788","title":"Extracellular Electrophysiology in the Prostate Cancer Cell Model PC-3.","date":"2019","source":"Sensors (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/30609788","citation_count":18,"is_preprint":false},{"pmid":"16886623","id":"PMC_16886623","title":"Inhibition of caveolin-1 expression by incadronate in PC-3 prostate cells.","date":"2006","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16886623","citation_count":18,"is_preprint":false},{"pmid":"19615363","id":"PMC_19615363","title":"Skp2 enhances polyubiquitination and degradation of TIS21/BTG2/PC3, tumor suppressor protein, at the downstream of FoxM1.","date":"2009","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/19615363","citation_count":18,"is_preprint":false},{"pmid":"15741235","id":"PMC_15741235","title":"The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.","date":"2005","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/15741235","citation_count":18,"is_preprint":false},{"pmid":"26028116","id":"PMC_26028116","title":"Inhibition of Transient Receptor Potential Melastain 7 Enhances Apoptosis Induced by TRAIL in PC-3 cells.","date":"2015","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/26028116","citation_count":17,"is_preprint":false},{"pmid":"29301501","id":"PMC_29301501","title":"Inhibition of neddylation facilitates cell migration through enhanced phosphorylation of caveolin-1 in PC3 and U373MG cells.","date":"2018","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29301501","citation_count":17,"is_preprint":false},{"pmid":"33684465","id":"PMC_33684465","title":"Investigation of molecular mechanisms underlying the antiproliferative effects of colchicine against PC3 prostate cancer cells.","date":"2021","source":"Toxicology in vitro : an international journal published in association with BIBRA","url":"https://pubmed.ncbi.nlm.nih.gov/33684465","citation_count":17,"is_preprint":false},{"pmid":"30808588","id":"PMC_30808588","title":"Calcilytics inhibit the proliferation and migration of human prostate cancer PC-3 cells.","date":"2019","source":"Journal of pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30808588","citation_count":17,"is_preprint":false},{"pmid":"27430422","id":"PMC_27430422","title":"Sulforaphane-cysteine suppresses invasion via downregulation of galectin-1 in human prostate cancer DU145 and PC3 cells.","date":"2016","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/27430422","citation_count":17,"is_preprint":false},{"pmid":"22783964","id":"PMC_22783964","title":"Implications of pleiotrophin in human PC3 prostate cancer cell growth in vivo.","date":"2012","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/22783964","citation_count":17,"is_preprint":false},{"pmid":"27555324","id":"PMC_27555324","title":"A Novel Role of Chromodomain Protein CBX8 in DNA Damage Response.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27555324","citation_count":16,"is_preprint":false},{"pmid":"34689298","id":"PMC_34689298","title":"Enhanced cadmium removal by growing Bacillus cereus RC-1 immobilized on different magnetic biochars through simultaneous adsorption and bioaccumulation.","date":"2021","source":"Environmental science and pollution research international","url":"https://pubmed.ncbi.nlm.nih.gov/34689298","citation_count":16,"is_preprint":false},{"pmid":"16777715","id":"PMC_16777715","title":"Safrole-induced Ca2+ mobilization and cytotoxicity in human PC3 prostate cancer cells.","date":"2006","source":"Journal of receptor and signal transduction research","url":"https://pubmed.ncbi.nlm.nih.gov/16777715","citation_count":16,"is_preprint":false},{"pmid":"25398592","id":"PMC_25398592","title":"Insulin-Like Growth Factor-1 Modulates Polycomb Cbx8 Expression and Inhibits Colon Cancer Cell Apoptosis.","date":"2015","source":"Cell biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/25398592","citation_count":16,"is_preprint":false},{"pmid":"32841893","id":"PMC_32841893","title":"Induction of proliferative and mutagenic activity by benzo(a)pyrene in PC-3 cells via JAK2/STAT3 pathway.","date":"2020","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/32841893","citation_count":15,"is_preprint":false},{"pmid":"7923822","id":"PMC_7923822","title":"Expression patterns of messenger ribonucleic acids encoding prohormone convertases (PC2 and PC3) in human pituitary adenomas.","date":"1994","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/7923822","citation_count":15,"is_preprint":false},{"pmid":"29541177","id":"PMC_29541177","title":"RNA interference-mediated depletion of TRPM8 enhances the efficacy of epirubicin chemotherapy in prostate cancer LNCaP and PC3 cells.","date":"2018","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/29541177","citation_count":15,"is_preprint":false},{"pmid":"31289542","id":"PMC_31289542","title":"Trichostatin A inhibits proliferation of PC3 prostate cancer cells by disrupting the EGFR pathway.","date":"2019","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/31289542","citation_count":15,"is_preprint":false},{"pmid":"36063535","id":"PMC_36063535","title":"Saffron extract feed improves the antioxidant status of laying hens and the inhibitory effect on cancer cells (PC3 and MCF7) Growth.","date":"2022","source":"Veterinary medicine and science","url":"https://pubmed.ncbi.nlm.nih.gov/36063535","citation_count":14,"is_preprint":false},{"pmid":"31274029","id":"PMC_31274029","title":"Glycyrrhiza glabra-Enhanced Extract and Adriamycin Antiproliferative Effect on PC-3 Prostate Cancer Cells.","date":"2019","source":"Nutrition and cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31274029","citation_count":14,"is_preprint":false},{"pmid":"16019130","id":"PMC_16019130","title":"Incadronate inhibits aminopeptidase N expression in prostatic PC-3 cells.","date":"2005","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/16019130","citation_count":14,"is_preprint":false},{"pmid":"28849151","id":"PMC_28849151","title":"Effect of silencing the T‑Box transcription factor TBX2 in prostate cancer PC3 and LNCaP cells.","date":"2017","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/28849151","citation_count":14,"is_preprint":false},{"pmid":"20881502","id":"PMC_20881502","title":"Downregulation of Id1 by small interfering RNA in prostate cancer PC3 cells in vivo and in vitro.","date":"2011","source":"European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)","url":"https://pubmed.ncbi.nlm.nih.gov/20881502","citation_count":14,"is_preprint":false},{"pmid":"27347470","id":"PMC_27347470","title":"l-2-Haloacid dehalogenase (DehL) from Rhizobium sp. RC1.","date":"2016","source":"SpringerPlus","url":"https://pubmed.ncbi.nlm.nih.gov/27347470","citation_count":13,"is_preprint":false},{"pmid":"23917204","id":"PMC_23917204","title":"TIS21(/BTG2/PC3) inhibits interleukin-6 expression via downregulation of STAT3 pathway.","date":"2013","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/23917204","citation_count":13,"is_preprint":false},{"pmid":"30367494","id":"PMC_30367494","title":"PROSTAGLANDIN E2 stimulates cancer-related phenotypes in prostate cancer PC3 cells through cyclooxygenase-2.","date":"2018","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30367494","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48430,"output_tokens":3938,"usd":0.10218},"stage2":{"model":"claude-opus-4-6","input_tokens":7405,"output_tokens":2891,"usd":0.16395},"total_usd":0.26613,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"CBX8, as part of a PRC1 complex, directly binds to the INK4A-ARF locus and represses it, leading to bypass of senescence and cellular immortalization when CBX8 is ectopically expressed in diploid human and mouse fibroblasts.\",\n      \"method\": \"ChIP (location analysis), ectopic expression, gene expression profiling, loss-of-function in fibroblasts\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal ChIP and functional KO/OE with defined cellular phenotype (senescence bypass), replicated across human and mouse cells\",\n      \"pmids\": [\"17332741\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CBX8 interacts with MLL-AF9 and TIP60, and is required for MLL-AF9-induced transcriptional activation of HOX genes and leukemic transformation; point mutations disrupting the CBX8–MLL-AF9 interaction abrogate HOX gene upregulation and abolish leukemogenesis.\",\n      \"method\": \"Co-immunoprecipitation, point mutation analysis, Cbx8 knockout mice, retroviral transformation assays, gene expression analysis\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, point-mutation disruption, and clean KO with defined leukemia phenotype\",\n      \"pmids\": [\"22094252\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CBX8 is induced in germinal center B cells, binds H3K27me3 at bivalent promoters via its chromodomain, and is required for stable association of a non-canonical PRC1-BCOR-CBX8 complex assembled by EZH2 and BCL6, mediating histone modifications and GC formation.\",\n      \"method\": \"ChIP-seq, Co-IP, genetic knockdown, functional GC formation assays\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq, Co-IP, and KD with defined cellular phenotype (GC formation), multiple orthogonal methods\",\n      \"pmids\": [\"27505670\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"A Cbx8-containing PRC1 complex facilitates transcriptional activation of differentiation genes during ES cell differentiation; Cbx8 transiently recruits to bivalent promoters during early gene activation and is required for efficient activation, with exchange of Cbx7 for Cbx8 being necessary for this process.\",\n      \"method\": \"ChIP-seq of endogenous Cbx8, interaction analysis (co-IP), siRNA depletion, microarray gene expression\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide ChIP-seq, interaction analysis, and depletion with defined transcriptional phenotype in ES cells\",\n      \"pmids\": [\"25500566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The CBX8 chromodomain drives chromatin association through dual binding to both H3K27me3 histone marks and DNA; structural characterization revealed how histone and DNA binding integrate, and both activities were required for CBX8 chromatin association in vivo.\",\n      \"method\": \"Biochemical binding assays (in vitro), structural characterization, ChIP in cells, mutagenesis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution and structural characterization combined with in vivo ChIP validation and mutagenesis\",\n      \"pmids\": [\"30597065\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A selective, cell-permeable CBX8 chromodomain inhibitor (SW2_110A) developed via DNA-encoded library selection binds the CBX8 ChD with Kd ~800 nM, specifically inhibits CBX8 chromatin association in cells, and reduces MLL-AF9 target gene (HOXA9) expression and proliferation of THP1 leukemia cells, validating the chromodomain as necessary for CBX8's role in MLL-AF9 transcriptional activation.\",\n      \"method\": \"DNA-encoded library selection, fluorescence polarization, cell-based chromatin association assay, gene expression analysis, proliferation assay\",\n      \"journal\": \"ACS chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro binding assay with selectivity profiling, cell-permeable probe with functional cellular readout\",\n      \"pmids\": [\"31755685\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CBX8 activates AKT/β-catenin signaling in hepatocellular carcinoma in a non-canonical manner: CBX8 directly binds the EGR1 promoter to enhance transcription and also interacts with EGR1 protein in the nucleus to prevent its degradation; additionally, CBX8 upregulates miR-365a-3p which promotes nuclear β-catenin localization by targeting ZNRF1.\",\n      \"method\": \"ChIP, co-immunoprecipitation, luciferase reporter assay, siRNA knockdown, ectopic expression, in vivo xenograft\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP, Co-IP, reporter assay, and in vivo validation with multiple orthogonal methods\",\n      \"pmids\": [\"29066512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CBX8 accumulates rapidly at sites of DNA damage within 30 seconds in a PARP1-dependent (but ATM-independent) manner; CBX8 biochemically interacts with TRIM33, and its recruitment to DNA damage sites requires TRIM33; CBX8 knockdown reduces efficiency of both homologous and non-homologous recombination and increases sensitivity to ionizing radiation.\",\n      \"method\": \"Live-cell imaging, co-immunoprecipitation, siRNA knockdown, DNA repair assays (HR/NHEJ reporters), clonogenic survival\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — live imaging with defined kinetics, Co-IP, and loss-of-function with functional DNA repair readouts\",\n      \"pmids\": [\"27555324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CBX8 knockdown in colorectal cancer cells inhibits proliferation (partly by increasing p53 and downstream effectors) but paradoxically enhances migration, invasion and metastasis through direct upregulation of integrin β4 (ITGB4), which in turn decreases RhoA activity.\",\n      \"method\": \"siRNA knockdown, in vitro migration/invasion assays, in vivo metastasis assay, gene expression analysis, ChIP\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD with defined cellular phenotypes (proliferation, migration) and mechanistic target identification, single lab\",\n      \"pmids\": [\"25360999\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CBX8 suppresses tumor metastasis in esophageal squamous cell carcinoma by directly binding the Snail promoter and repressing its transcription, thereby inhibiting EMT; CBX8 expression inversely correlates with Snail in ESCC tissues.\",\n      \"method\": \"ChIP, luciferase reporter assay, siRNA/overexpression, migration/invasion assays, in vivo metastasis model\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and reporter assay with functional readout, single lab\",\n      \"pmids\": [\"28912889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CBX8 promotes LGR5 transcription in a non-canonical manner by recruiting KMT2b to the LGR5 promoter, maintaining H3K4me3 status; additionally, m6A methylation upregulates CBX8 by maintaining CBX8 mRNA stability.\",\n      \"method\": \"ChIP-seq, RNA-seq, ChIP, co-immunoprecipitation, dual luciferase reporter assay, IP\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq, Co-IP, reporter assays with multiple orthogonal methods, single lab\",\n      \"pmids\": [\"31849331\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"KPNA2 promotes nuclear import of CBX8; once nuclear, CBX8 downregulates PRDM1 by recruiting BCOR to the PRDM1 promoter region, leading to suppression of the PRDM1/c-FOS pathway and promotion of bladder cancer progression.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, siRNA knockdown, overexpression, in vivo mouse model\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP, ChIP, and functional KD/OE with defined pathway, single lab\",\n      \"pmids\": [\"33731128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CBX8 promotes tumorigenesis in esophageal squamous cell carcinoma by downregulating APAF1 expression (identified via transcriptome sequencing), thereby suppressing the mitochondrial apoptotic pathway and conferring radioresistance.\",\n      \"method\": \"Transcriptome sequencing, ChIP (implied), siRNA knockdown, apoptosis assays, irradiation survival assay\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — transcriptome sequencing combined with functional rescue (APAF1 depletion abrogates CBX8-KD apoptosis), single lab\",\n      \"pmids\": [\"31255735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CBX8 suppresses Sirtinol-induced premature senescence in K562 CML cells by enhancing phosphorylation of AKT1, p27KIP1, and RB, thereby promoting E2F1 transcriptional activity; CBX8 knockdown reverses this effect, placing CBX8 in the AKT-RB-E2F1 pathway.\",\n      \"method\": \"CBX8 overexpression and siRNA knockdown, Western blot for pathway components, senescence assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — OE/KD with pathway component analysis, single lab, no direct binding assay\",\n      \"pmids\": [\"26718407\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CBX8 promotes invasion and migration in glioblastoma, breast cancer, and lung cancer by binding the WNK2 promoter to suppress WNK2 expression; reduced WNK2 leads to elevated MMP2 and RAC1 activity, which drive invasion and migration respectively.\",\n      \"method\": \"ChIP, siRNA knockdown, overexpression, invasion/migration assays, in vivo xenograft\",\n      \"journal\": \"Molecular therapy oncolytics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with functional validation in multiple cancer types, single lab\",\n      \"pmids\": [\"33251331\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"IGF1 increases CBX8 expression in HCT116 colon cancer cells; CBX8 overexpression promotes proliferation (upregulates CyclinD1) and knockdown induces apoptosis, placing CBX8 downstream of IGF1 signaling in colon cancer.\",\n      \"method\": \"Gene silencing (siRNA), overexpression, Western blot, RT-PCR, cell proliferation assay\",\n      \"journal\": \"Cell biochemistry and biophysics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, single method set (KD/OE + Western blot), no direct binding or mechanistic detail\",\n      \"pmids\": [\"25398592\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CBX8 interacts with YBX1, and YBX1-mediated regulation of CyclinD1 is required for CBX8-driven cell cycle progression and proliferation in hepatocellular carcinoma cells; YBX1 knockdown compromises proliferation of CBX8-overexpressing cells.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, overexpression, Western blot, GSEA\",\n      \"journal\": \"Aging\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP and KD with functional readout, single lab, no structural detail\",\n      \"pmids\": [\"31495785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DNA-encoded positional scanning library selections against the CBX8 chromodomain identified peptidomimetic ligands with increased potency and selectivity for CBX8 ChD over CBX7 ChD, characterizing the structural requirements for selective ChD binding.\",\n      \"method\": \"DNA-encoded library affinity selection, fluorescence polarization, sequencing\",\n      \"journal\": \"SLAS discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical assay with quantitative SAR, validated off-DNA with FP, single lab\",\n      \"pmids\": [\"29309209\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CBX8 is a chromodomain-containing Polycomb group protein that associates with PRC1 complexes and binds H3K27me3 and DNA via its chromodomain to regulate chromatin state; it represses key loci (including INK4A-ARF) to bypass senescence, functions in a non-canonical activating capacity during ES cell differentiation, is required for MLL-AF9–driven leukemogenesis through interaction with MLL-AF9 and TIP60, participates in PARP1-dependent DNA damage response via interaction with TRIM33, and modulates cancer cell proliferation and metastasis through context-dependent transcriptional regulation of targets including Snail, WNK2, APAF1, and LGR5.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CBX8 is a chromodomain-containing Polycomb group protein that functions as a context-dependent transcriptional regulator, mediating both gene repression within PRC1 complexes and non-canonical transcriptional activation at distinct genomic loci. Its chromodomain drives chromatin association through dual recognition of H3K27me3 and DNA, and CBX8 occupies bivalent promoters where it represses the INK4A-ARF locus to bypass senescence, silences differentiation regulators in germinal center B cells via a non-canonical PRC1-BCOR complex assembled by EZH2/BCL6, and facilitates activation of differentiation genes during ES cell differentiation through Cbx7-to-Cbx8 exchange [PMID:17332741, PMID:27505670, PMID:25500566, PMID:30597065]. CBX8 is required for MLL-AF9-driven leukemogenesis through direct interaction with MLL-AF9 and TIP60, enabling transcriptional activation of HOX genes, and its chromodomain is pharmacologically targetable to block this oncogenic program [PMID:22094252, PMID:31755685]. CBX8 also participates in DNA damage repair by rapid PARP1- and TRIM33-dependent recruitment to damage sites, where it promotes both homologous recombination and non-homologous end joining [PMID:27555324].\",\n  \"teleology\": [\n    {\n      \"year\": 2007,\n      \"claim\": \"Establishing CBX8 as a PRC1 component that directly represses the INK4A-ARF tumor suppressor locus resolved how Polycomb chromobox proteins control replicative senescence and cellular immortalization.\",\n      \"evidence\": \"ChIP at INK4A-ARF, ectopic expression in human/mouse fibroblasts causing senescence bypass\",\n      \"pmids\": [\"17332741\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How CBX8 is selectively recruited to INK4A-ARF versus other PRC1 targets was not addressed\",\n        \"Whether CBX8's chromodomain histone-binding activity is required for INK4A-ARF repression was untested\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrating that CBX8 physically interacts with MLL-AF9 and TIP60 and is essential for HOX gene activation and leukemic transformation revealed an unexpected non-canonical activating role for a Polycomb protein in oncogenesis.\",\n      \"evidence\": \"Co-IP, point-mutation disruption of CBX8–MLL-AF9 interaction, Cbx8 knockout mice, retroviral transformation assays\",\n      \"pmids\": [\"22094252\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether TIP60 acetyltransferase activity is the effector downstream of CBX8 recruitment was not tested\",\n        \"Structural basis of the CBX8–MLL-AF9 interaction was not determined\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Showing that Cbx8 transiently replaces Cbx7 at bivalent promoters during ES cell differentiation to enable gene activation established a Polycomb subunit-switching mechanism controlling developmental transcription.\",\n      \"evidence\": \"Endogenous Cbx8 ChIP-seq, Co-IP, siRNA depletion, microarray in differentiating ES cells\",\n      \"pmids\": [\"25500566\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The signal triggering the Cbx7-to-Cbx8 switch was not identified\",\n        \"Whether the activating PRC1 complex containing Cbx8 has a distinct subunit composition from canonical PRC1 was not fully resolved\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Two studies expanded CBX8's mechanistic repertoire: identification of a non-canonical PRC1-BCOR-CBX8 complex at bivalent promoters in germinal center B cells, and discovery of rapid PARP1/TRIM33-dependent CBX8 recruitment to DNA damage sites required for both HR and NHEJ.\",\n      \"evidence\": \"ChIP-seq and Co-IP with GC formation assays (GC study); live-cell imaging, Co-IP with TRIM33, HR/NHEJ reporter assays (DNA damage study)\",\n      \"pmids\": [\"27505670\", \"27555324\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How TRIM33 physically recruits CBX8 to damage sites and whether the chromodomain is required for this function were not determined\",\n        \"Whether PRC1-BCOR-CBX8 complex has distinct enzymatic activity (e.g., ubiquitin ligase) compared to canonical PRC1 was not tested\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Context-dependent transcriptional regulation by CBX8 was elaborated in cancer: CBX8 activates EGR1/AKT/β-catenin signaling in hepatocellular carcinoma while repressing Snail to suppress EMT in esophageal squamous cell carcinoma, illustrating dual activator/repressor functions at different loci.\",\n      \"evidence\": \"ChIP, Co-IP, luciferase reporters, siRNA/overexpression, in vivo metastasis models in HCC and ESCC\",\n      \"pmids\": [\"29066512\", \"28912889\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"What determines whether CBX8 acts as an activator versus repressor at a given promoter is unknown\",\n        \"Whether these cancer-context functions depend on PRC1 complex membership was not tested\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Structure-activity analysis of the CBX8 chromodomain using DNA-encoded library selections identified selective peptidomimetic ligands, defining the structural requirements distinguishing CBX8 from CBX7 chromodomain binding.\",\n      \"evidence\": \"DNA-encoded library affinity selection with fluorescence polarization validation\",\n      \"pmids\": [\"29309209\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No cell-based validation of these ligands was reported in this study\",\n        \"Co-crystal structure of ligand–CBX8 ChD was not obtained\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Structural and biochemical characterization demonstrated that the CBX8 chromodomain binds both H3K27me3 and DNA simultaneously, and a cell-permeable chromodomain inhibitor validated this dual-binding mode as essential for CBX8 chromatin association and MLL-AF9 target gene expression.\",\n      \"evidence\": \"In vitro binding assays, structural characterization, mutagenesis, ChIP; DNA-encoded library-derived inhibitor SW2_110A with cellular chromatin association and proliferation assays in THP1 cells\",\n      \"pmids\": [\"30597065\", \"31755685\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Full atomic-resolution structure of CBX8 ChD bound simultaneously to nucleosomal DNA and H3K27me3 is lacking\",\n        \"Whether inhibitor efficacy extends to in vivo leukemia models was not shown\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Non-canonical transcriptional activation by CBX8 was further demonstrated at the LGR5 locus, where CBX8 recruits KMT2b to maintain H3K4me3, and CBX8 mRNA itself is stabilized by m6A modification, linking epitranscriptomic regulation to Polycomb function.\",\n      \"evidence\": \"ChIP-seq, RNA-seq, Co-IP, dual luciferase reporter assay\",\n      \"pmids\": [\"31849331\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct interaction between CBX8 and KMT2b was not structurally characterized\",\n        \"Which m6A writer/reader mediates CBX8 mRNA stabilization was not fully identified\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of KPNA2 as a CBX8 nuclear import factor and demonstration that nuclear CBX8 recruits BCOR to repress PRDM1 in bladder cancer connected nuclear trafficking to CBX8's repressive output.\",\n      \"evidence\": \"Co-IP, ChIP, siRNA/overexpression, in vivo mouse model\",\n      \"pmids\": [\"33751128\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether KPNA2-dependent import is regulated or constitutive was not addressed\",\n        \"Whether CBX8 uses the same BCOR recruitment mechanism in GC B cells and bladder cancer was not compared\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The central unresolved question is what determines whether CBX8 acts as a transcriptional repressor (via PRC1/BCOR) or activator (via MLL-AF9/TIP60/KMT2b) at a given locus, and how its dual H3K27me3-DNA binding mode integrates with these distinct complexes genome-wide.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No systematic genome-wide comparison of CBX8 activating versus repressive targets with matched complex composition\",\n        \"In vivo efficacy of CBX8 chromodomain inhibitors has not been demonstrated\",\n        \"Whether the DNA damage response role of CBX8 is separable from its PRC1-associated functions is unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [0, 2, 3, 4]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 3, 6, 9, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 6, 7, 11]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [2, 3, 4, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0, 2, 3, 4, 10]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 6, 9, 10]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [1, 5, 6]}\n    ],\n    \"complexes\": [\n      \"PRC1\",\n      \"PRC1-BCOR-CBX8\"\n    ],\n    \"partners\": [\n      \"RING1B\",\n      \"MLL-AF9\",\n      \"TIP60\",\n      \"TRIM33\",\n      \"BCOR\",\n      \"EGR1\",\n      \"YBX1\",\n      \"KMT2B\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}